Skip to content

A randomized controlled study of the efficacy of different doses of PRP in the treatment of moderate carpal tunnel syndrome

A randomized controlled study of the efficacy of different doses of PRP in the treatment of moderate carpal tunnel syndrome

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082817
Enrollment
Unknown
Registered
2024-04-09
Start date
2024-04-10
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal tunnel syndrome

Interventions

5ml PRP:Inject 5mL PRP into the carpal tunnel
3ml PRP:Inject 3mL PRP into the carpal tunnel

Sponsors

The Sixth Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) 20-80 years old; (2) patients diagnosed with moderate carpal tunnel syndrome according to electromyography; (3) carpal tunnel symptoms lasting for =1 month; (4) VAS numbness score =4 points (5) normal platelet count and coagulation function; (6) no long-term history of smoking or drinking; (7) without language or cognitive impairment; (8) voluntarily participate in this trial and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) previous or planned wrist surgery within six months or previous history of severe wrist trauma; (2) patients who received any injection in carpal tunnel within the past 4 weeks; (3) serious skin damage or ulcers around the wrist; (4) patients with systemic use of corticosteroids in the past 2 weeks and non-steroidal anti-inflammatory drugs in the past 1 week; (5) patients who used anticoagulant or antiplatelet drugs in the past one month; (6) patients with diabetes, gout, metabolic, digestive tract, tumor, blood system and other basic diseases; (7) cervical spondylosis, brachial plexus disease, lateral epicondylitis, thoracic outlet syndrome, and other diseases; (8) pregnant and lactating women; (9) patients with hemoglobin <10g/L, platelet count < 150x10^9/L; (10) patients with a history of infectious diseases, eight tests of hepatitis B, HIV and syphilis were positive before operation; Recent febrile illness; (11) non-invasive contraindications or previous participation in similar experiments with carpal tunnel PRP injection.

Design outcomes

Primary

MeasureTime frame
VAS score for numbness;

Secondary

MeasureTime frame
BCTQ-SSS;BCTQ-FSS;SNCV;DML;Cross sectional area of median nerve under ultrasound;Blood flow to the median nerve;Median nerve swelling rate;

Countries

China

Contacts

Public ContactLi Jiang

The Sixth Affiliated Hospital of Sun Yat-sen University

jiangli0909@163.com+86 158 0004 5323

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026